John Bradway, MD
Orthopaedic Surgery · Scottsdale, AZNPI 1215987557
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $217,649 of the $219,307 with a category attached, or 99.2%. Ortho Development Corporation accounts for 99.9% of it on its own, with 3 other manufacturers making up the rest. Among orthopaedic surgery clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 165 payments — averaging $1329.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ortho Development Corporation$219K
- Johnson & Johnson$180
- Baxter Healthcare$20
- Orthofix Medical, Inc.$4
What the payments were for
- Royalty or licence$217,64999%
- Travel & lodging$1,1771%
- Food & beverage$4810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ortho Development Corporation | 154 | $219,103 |
| Johnson & Johnson | 9 | $180 |
| Baxter Healthcare | 1 | $20 |
| Orthofix Medical, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Escalade Acetabular System$97,572
- Alpine Hip System$88,930
- Escalade$66,232
- Alpine$17,861
- Ovation Tribute Hip Stem$152
How this compares
$219,307 in reported general payments places this provider in the 90th percentile of 377 orthopaedic surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 76 | $578 |
| Celecoxib | 24 | $245 |
| Meloxicam | 114 | $222 |
| Amoxicillin | 32 | $70 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Scottsdale
- Paul GauseScottsdale$614K
- Bertrand KaperScottsdale$482K
- David CamarataScottsdale$406K
- David BailieScottsdale$249K
- Shane MartinScottsdale$244K
- Sherwood DuhonScottsdale$229K
- Krishna MallikScottsdale$79K
- Timothy KavanaughScottsdale$71K
- Laura ProkuskiScottsdale$58K
- Paul GoodwynScottsdale$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.